1. Rosenkranz B, Winkelmann BR, Parnham MJ. Clinical pharmacokinetics of molsidomine. Clin Pharmacokinet. 1996;30:372–84.
2. Kirsten R, Nelson K, Kirsten D, Heintz B. Clinical pharmacokinetics of vasodilators. Part II. Clin Pharmacokinet. 1998;35:9–36.
3. Hug J, Hasenfuss G, Wollschläger H, Just HJ, Bonzel T. Coronary dilation after intracoronary administration of SIN-1 and intravenous molsidomine administration [in German]. Med Klin. 1994;89(Suppl 2):34–7.
4. Münzel T, Kurz S, Heitzer T, Luhmann C, Just HJ. Effects of intravenous administration of nitroglycerin and SIN-1 or molsidomine on epicardial arterial diameter in patients with stable coronary heart disease [in German]. Med Klin. 1994;89(Suppl 2):38–41.
5. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad USA. 1987;84:9265–9.